Elevation of MCP-1 and MCP-1/VEGF ratio in cerebrospinal fluid of amyotrophic lateral sclerosis patients

Tetsuya Nagata, Isao Nagano, Mito Shiote, Hisashi Narai, Tetsuro Murakami, Takeshi Hayashi, Mikio Shoji, Koji Abe

Research output: Contribution to journalArticle

37 Citations (Scopus)

Abstract

Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease with progressive cell death of upper and lower motor neurons. In this study, we measured monocyte chemotactic protein-1 (MCP-1) and vascular endothelial growth factor (VEGF) levels in cerebrospinal fluid (CSF) and serum by enzyme-linked immunosorbent assay (ELISA) in 42 ALS patients, and compared these levels with those of control subjects with other neurodegenerative disorders or with those of normal controls. MCP-1 levels in CSF were significantly higher in ALS patients than in the control group. VEGF levels in CSF tended to be lower in ALS patients than in the control group, but not significantly. A positive correlation was found between MCP-1 levels in CSF of ALS patients and the total Norris scale. The elevation of MCP-1/VEGF ratio in CSF was more specific to ALS patients compared to other neurological diseases such as Parkinson's disease (PD) and spinocerebellar ataxia (SCA) and to controls. Our data suggested that both MCP-1 levels and MCP-1/VEGF ratio in CSF may be useful markers for the clinical diagnosis of ALS.

Original languageEnglish
Pages (from-to)772-776
Number of pages5
JournalNeurological Research
Volume29
Issue number8
DOIs
Publication statusPublished - Dec 2007

Fingerprint

Chemokine CCL2
Amyotrophic Lateral Sclerosis
Vascular Endothelial Growth Factor A
Cerebrospinal Fluid
Neurodegenerative Diseases
Spinocerebellar Ataxias
Control Groups
Motor Neurons
Parkinson Disease
Cell Death
Biomarkers
Enzyme-Linked Immunosorbent Assay
Serum

Keywords

  • Amyotrophic lateral sclerosis
  • Cerebrospinal fluid
  • MCP-1
  • Vascular endothelial growth factor

ASJC Scopus subject areas

  • Clinical Neurology
  • Neuroscience(all)

Cite this

Elevation of MCP-1 and MCP-1/VEGF ratio in cerebrospinal fluid of amyotrophic lateral sclerosis patients. / Nagata, Tetsuya; Nagano, Isao; Shiote, Mito; Narai, Hisashi; Murakami, Tetsuro; Hayashi, Takeshi; Shoji, Mikio; Abe, Koji.

In: Neurological Research, Vol. 29, No. 8, 12.2007, p. 772-776.

Research output: Contribution to journalArticle

Nagata, T, Nagano, I, Shiote, M, Narai, H, Murakami, T, Hayashi, T, Shoji, M & Abe, K 2007, 'Elevation of MCP-1 and MCP-1/VEGF ratio in cerebrospinal fluid of amyotrophic lateral sclerosis patients', Neurological Research, vol. 29, no. 8, pp. 772-776. https://doi.org/10.1179/016164107X229795
Nagata, Tetsuya ; Nagano, Isao ; Shiote, Mito ; Narai, Hisashi ; Murakami, Tetsuro ; Hayashi, Takeshi ; Shoji, Mikio ; Abe, Koji. / Elevation of MCP-1 and MCP-1/VEGF ratio in cerebrospinal fluid of amyotrophic lateral sclerosis patients. In: Neurological Research. 2007 ; Vol. 29, No. 8. pp. 772-776.
@article{c20853b8094d4b0381ef2b81fb11f94d,
title = "Elevation of MCP-1 and MCP-1/VEGF ratio in cerebrospinal fluid of amyotrophic lateral sclerosis patients",
abstract = "Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease with progressive cell death of upper and lower motor neurons. In this study, we measured monocyte chemotactic protein-1 (MCP-1) and vascular endothelial growth factor (VEGF) levels in cerebrospinal fluid (CSF) and serum by enzyme-linked immunosorbent assay (ELISA) in 42 ALS patients, and compared these levels with those of control subjects with other neurodegenerative disorders or with those of normal controls. MCP-1 levels in CSF were significantly higher in ALS patients than in the control group. VEGF levels in CSF tended to be lower in ALS patients than in the control group, but not significantly. A positive correlation was found between MCP-1 levels in CSF of ALS patients and the total Norris scale. The elevation of MCP-1/VEGF ratio in CSF was more specific to ALS patients compared to other neurological diseases such as Parkinson's disease (PD) and spinocerebellar ataxia (SCA) and to controls. Our data suggested that both MCP-1 levels and MCP-1/VEGF ratio in CSF may be useful markers for the clinical diagnosis of ALS.",
keywords = "Amyotrophic lateral sclerosis, Cerebrospinal fluid, MCP-1, Vascular endothelial growth factor",
author = "Tetsuya Nagata and Isao Nagano and Mito Shiote and Hisashi Narai and Tetsuro Murakami and Takeshi Hayashi and Mikio Shoji and Koji Abe",
year = "2007",
month = "12",
doi = "10.1179/016164107X229795",
language = "English",
volume = "29",
pages = "772--776",
journal = "Neurological Research",
issn = "0161-6412",
publisher = "Maney Publishing",
number = "8",

}

TY - JOUR

T1 - Elevation of MCP-1 and MCP-1/VEGF ratio in cerebrospinal fluid of amyotrophic lateral sclerosis patients

AU - Nagata, Tetsuya

AU - Nagano, Isao

AU - Shiote, Mito

AU - Narai, Hisashi

AU - Murakami, Tetsuro

AU - Hayashi, Takeshi

AU - Shoji, Mikio

AU - Abe, Koji

PY - 2007/12

Y1 - 2007/12

N2 - Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease with progressive cell death of upper and lower motor neurons. In this study, we measured monocyte chemotactic protein-1 (MCP-1) and vascular endothelial growth factor (VEGF) levels in cerebrospinal fluid (CSF) and serum by enzyme-linked immunosorbent assay (ELISA) in 42 ALS patients, and compared these levels with those of control subjects with other neurodegenerative disorders or with those of normal controls. MCP-1 levels in CSF were significantly higher in ALS patients than in the control group. VEGF levels in CSF tended to be lower in ALS patients than in the control group, but not significantly. A positive correlation was found between MCP-1 levels in CSF of ALS patients and the total Norris scale. The elevation of MCP-1/VEGF ratio in CSF was more specific to ALS patients compared to other neurological diseases such as Parkinson's disease (PD) and spinocerebellar ataxia (SCA) and to controls. Our data suggested that both MCP-1 levels and MCP-1/VEGF ratio in CSF may be useful markers for the clinical diagnosis of ALS.

AB - Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease with progressive cell death of upper and lower motor neurons. In this study, we measured monocyte chemotactic protein-1 (MCP-1) and vascular endothelial growth factor (VEGF) levels in cerebrospinal fluid (CSF) and serum by enzyme-linked immunosorbent assay (ELISA) in 42 ALS patients, and compared these levels with those of control subjects with other neurodegenerative disorders or with those of normal controls. MCP-1 levels in CSF were significantly higher in ALS patients than in the control group. VEGF levels in CSF tended to be lower in ALS patients than in the control group, but not significantly. A positive correlation was found between MCP-1 levels in CSF of ALS patients and the total Norris scale. The elevation of MCP-1/VEGF ratio in CSF was more specific to ALS patients compared to other neurological diseases such as Parkinson's disease (PD) and spinocerebellar ataxia (SCA) and to controls. Our data suggested that both MCP-1 levels and MCP-1/VEGF ratio in CSF may be useful markers for the clinical diagnosis of ALS.

KW - Amyotrophic lateral sclerosis

KW - Cerebrospinal fluid

KW - MCP-1

KW - Vascular endothelial growth factor

UR - http://www.scopus.com/inward/record.url?scp=37149006825&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=37149006825&partnerID=8YFLogxK

U2 - 10.1179/016164107X229795

DO - 10.1179/016164107X229795

M3 - Article

VL - 29

SP - 772

EP - 776

JO - Neurological Research

JF - Neurological Research

SN - 0161-6412

IS - 8

ER -